COST-EFFECTIVENESS ANALYSIS OF LIPEGFILGRASTIM AS PRIMARY PROPHYLAXIS IN WOMEN WITH BREAST CANCER IN AUSTRALIA-A MODELED ECONOMIC EVALUATION

conference contribution

posted on 2024-06-04, 04:00 authored by Lan GaoLan Gao, SC Li

COST-EFFECTIVENESS ANALYSIS OF LIPEGFILGRASTIM AS PRIMARY PROPHYLAXIS IN WOMEN WITH BREAST CANCER IN AUSTRALIA-A MODELED ECONOMIC EVALUATION

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1016/j.jval.2018.07.106

Link to full text

http://www.valueinhealthjournal.com/article/S109830151832463X/pdf

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000458697200075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3 Extract of paper

Volume

21

Pagination

S14-S14

ISSN

1098-3015

eISSN

1524-4733

Title of proceedings

VALUE IN HEALTH

Publisher

ELSEVIER SCIENCE INC

Usage metrics

Categories

Keywords

Social Sciences Science & Technology Life Sciences & Biomedicine Economics Health Care Sciences & Services Health Policy & Services Business & Economics 3801 Applied economics

Licence

All Rights Reserved

Exports